載入...
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
BACKGROUND: The severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is extremely variable, ranging from asymptomatic patients to those who develop severe acute respiratory distress syndrome (ARDS). As for now, there are still no really effective therapies for coronavir...
Na minha lista:
| 發表在: | Crit Care |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7523258/ https://ncbi.nlm.nih.gov/pubmed/32993751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-03306-6 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|